致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human NKG2A&CD94, Avi-His-tag
目录号 NBL-240841
别名 NKG2A&CD94; CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94
外观 see COA
分子量 Arg100-Leu233(NKG2A) & Ser34-Ile179(CD94)
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 P26715-1(NKG2A)&Q13241-1(CD94)
备注2
目录号 规格 价格 库存状态  
NBL-240841-100ug 100ug Inquire Inquire
NBL-240841-1mg 1mg Inquire Inquire
NBL-240841-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human NKG2A&CD94, Avi-His-tag


Catalog#:

NBL-240841


Description:

NebuSelect™ Recombinant Biotinylated Human NKG2A&CD94, Avi-His-tag(Cat#NBL-240841) is expressed in HEK293 with His tag and Avi tag at the N-Terminus.It contains Arg100-Leu233(NKG2A)&Ser34-Ile179(CD94).


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 17.9 kDa (CD94)&18.3 kDa (NKG2A). Due to glycosylation, the protein migrates to 33-48 kDa based on Bis-Tris PAGE result.


Target Name:

NKG2A&CD94; CD159a; NKG2A; NKG2-A; CD94; NKG2A&CD94


Target Information:

The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies.


Amino Acid Sequence: 

Arg100-Leu233(NKG2A) & Ser34-Ile179(CD94)


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品